P

Inventor

ANDERSON DAVID C

US45 patents
⚠️ This page may combine multiple inventors who share the name “ANDERSON DAVID C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

RIGEL PHARMACEUTICALS INC

12 patents
US6979549B2Dec 27, 2005

Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a CLLD8 protein

RIGEL PHARMACEUTICALS INC5 citations73
US7425418B2Sep 16, 2008

Compounds that modulate processes associated with IgE production

RIGEL PHARMACEUTICALS INC3 citations62
US7378251B2May 27, 2008

Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a thioredoxin-like 32 kDa protein

RIGEL PHARMACEUTICALS INC2 citations62
US7604951B2Oct 20, 2009

Method for identifying compounds that modulate RXR associated processes with IgE production

RIGEL PHARMACEUTICALS INC1 citations51
US7598050B2Oct 6, 2009

Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a chloride intracellular channel 1 protein

RIGEL PHARMACEUTICALS INC1 citations51
US7563585B2Jul 21, 2009

Methods of assaying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a thioredoxin-like 32 kDa protein (TXNL)

RIGEL PHARMACEUTICALS INC0 citations51
US7422867B2Sep 9, 2008

Methods of identifying compounds that modulate IL-4 receptor mediated IgE synthesis utilizing a CLLD8 protein

RIGEL PHARMACEUTICALS INC0 citations51
US7374894B2May 20, 2008

Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a chloride intracellular channel 1 protein

RIGEL PHARMACEUTICALS INC0 citations51
US7241581B2Jul 10, 2007

Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a c-MYC protein

RIGEL PHARMACEUTICALS INC0 citations51
US7208289B2Apr 24, 2007

Methods of identifying compounds that modulate IL-4 receptor mediated IgE synthesis utilizing a CLLD8 protein

RIGEL PHARMACEUTICALS INC0 citations51
US7189523B2Mar 13, 2007

Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a B-cell associated protein

RIGEL PHARMACEUTICALS INC0 citations51
US7141434B2Nov 28, 2006

Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing an adenosine kinase

RIGEL PHARMACEUTICALS INC0 citations51

SOMATOGEN INC

10 patents

NEORX CORP

6 patents

UT BATTELLE LLC

4 patents

(unassigned)

3 patents

AMGEN INC

3 patents

IMI CORNELIUS INC

2 patents

BAXTER BIOTECH TECH SARL

2 patents

LUCENT TECHNOLOGIES INC

1 patent

UNIVERSAL AUTOMATED SYSTEMS IN

1 patent

OLDCASTLE BUILDINGENVELOPE INC

1 patent